Vultaggio Vincent

PAO and PFO at ZNTL

Sold, on record
$115k
Dollars the filings state
Form 4 sales
4
Latest Feb 10, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ZNTLZentalis Pharmaceuticals, Inc.PAO and PFO

Sales by reason

1
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ZNTLRoutine
    Oct 4, 2024 2024

    Sold 1,603 shares at $3.18 ($5k)

    Vultaggio Vincent, Principal Accounting Officer

    10b5-1 planSold 4.5% of holdings ($113k position)33,855 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ZNTLNo plan
    Feb 3, 2025 +122 days

    Sold 2,615 shares at $1.71 ($4k)

    Vultaggio Vincent, PAO and Interim PFO

    No 10b5-1 planSold 1.4% of holdings ($329k position)189,826 shares leftFiling

  3. 3 Form 4 sale ZNTLRoutine
    Feb 3, 2026 +365 days

    Sold 3,096 shares at $2.54 ($8k)

    Vultaggio Vincent, PAO and PFO

    10b5-1 planSold 1.6% of holdings ($483k position)186,730 shares leftFiling

  4. 4 Form 4 sale ZNTLUnusual
    Feb 10, 2026 +7 days

    Sold 40,224 shares at $2.42 ($98k)

    Vultaggio Vincent, PAO and PFO

    10b5-1 planSold 21.5% of holdings ($453k position)146,506 shares left15.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Vultaggio Vincent
Source
Feb 10, 2026Feb 10, 2026ZNTLPAO and PFOForm 4 sale40,224$98k21.5%UnusualSEC
Feb 3, 2026Feb 4, 2026ZNTLPAO and PFOForm 4 sale3,096$8k1.6%RoutineSEC
Feb 3, 2025Feb 5, 2025ZNTLPAO and Interim PFOForm 4 sale2,615$4k1.4%No planSEC
Oct 4, 2024Oct 4, 2024ZNTLPrincipal Accounting OfficerForm 4 sale1,603$5k4.5%RoutineSEC